Two Boston finalists named for 2018 SXSW Accelerator Pitch Event

From computers that can read human body language to teaching moms how to do computer coding, a wide variety of ideas are being peddled by the dozens of companies invited to pitch their business plans to a panel of expert judges at this year’s South by Southwest Accelerator Pitch Event…Two companies from Boston are in the mix:, a student debt-focused startup; and Nix, the maker of a hydration biosensor that informs athletes, soldiers, and laborers when to drink, […]

Benefit’s Automated Kiosk To Debut in Canada

Benefit first partnered with ZoomSystems in 2013 to create Glam up & away. ZoomSystems is the global leader in high-end automated retail. “With this ground-breaking partnership, ZoomSystems and Benefit Cosmetics are giving travelers on-the-go access to the beauty products they need and love,” says Pamela Strazdas, vice president, Customer Success, ZoomSystems. Read more >>

Corbus Pharmaceuticals Announces Agreement with FDA on Phase 2b Cystic Fibrosis Study Design with Pulmonary Exacerbations as Sole Primary Endpoint

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, today announced that it has reached agreement with the U.S. Food and Drug Administration (“FDA”) regarding the design of its next study of lenabasum (formerly known as anabasum), a novel, oral, pro-resolving drug, in the treatment of cystic fibrosis (“CF”). Read more >>

Myomo Completes Repayment of Loan to the Massachusetts Life Sciences Center

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and the Massachusetts Life Sciences Center (MLSC) today celebrated Myomo’s repayment of a $750,000 accelerator loan provided by the MLSC in 2011. Myomo completed repayment of the loan, which totaled $1,350,618 with interest, on December 13, 2017. Myomo Chairman and CEO Paul R. Gudonis presented a ceremonial check to Travis McCready, President and CEO of MLSC, during a ceremony at Myomo’s headquarters in the […]

‘Bone Glue’ Experiments on the ISS Test Possible Treatment for Osteoporosis

“If we can show that our material stimulates the production of new bone in the space environment, that will have a translational value back on Earth, that it could be used to someday treat patients with osteoporosis,” said Brian Hess, founder and CEO of Launchpad Medical, which created the glue. “But it could also be a material to help treat astronauts from the effects of deep space travel. That’s obviously a secondary reason of why we are studying this […]